Poor oral nutrition after allogeneic stem cell transplantation correlates significantly with severe graft-versus-host disease

Bone Marrow Transplantation

Volumn 38, Issue 9, 2006, Pages 629-633

  Mattsson, J ^a   Westin, S ^a   Edlund, S ^a   Remberger, M ^a  

^a KAROLINSKA UNIVERSITY HOSPITAL   (Sweden)

Author keywords

[No Author keywords available]

Indexed keywords

BUSULFAN; CYCLOPHOSPHAMIDE; CYCLOSPORIN A; GRANULOCYTE COLONY STIMULATING FACTOR; METHOTREXATE; MYCOPHENOLIC ACID 2 MORPHOLINOETHYL ESTER; OKT 3; PREDNISOLONE; THYMOCYTE ANTIBODY;

ACUTE GRAFT VERSUS HOST DISEASE; ACUTE GRANULOCYTIC LEUKEMIA; ACUTE LEUKEMIA; ACUTE LYMPHOCYTIC LEUKEMIA; ADULT; ALLOGENEIC STEM CELL TRANSPLANTATION; ARTICLE; CHRONIC LEUKEMIA; CONFIDENCE INTERVAL; CORRELATION ANALYSIS; DIETARY INTAKE; DISEASE PREDISPOSITION; DISEASE SEVERITY; FEMALE; HLA TYPING; HUMAN; IMMUNOSUPPRESSIVE TREATMENT; LYMPHOMA; MAJOR CLINICAL STUDY; MALE; MULTIPLE MYELOMA; MULTIVARIATE ANALYSIS; MYELODYSPLASTIC SYNDROME; MYELOFIBROSIS; NUTRITIONAL ASSESSMENT; NUTRITIONAL HEALTH; NUTRITIONAL STATUS; PARENTERAL NUTRITION; POSTOPERATIVE PERIOD; PRIORITY JOURNAL; RISK ASSESSMENT; T CELL DEPLETION;

ACUTE DISEASE; ADOLESCENT; ADULT; ENTERAL NUTRITION; FEMALE; GRAFT VS HOST DISEASE; HEMATOLOGIC NEOPLASMS; HUMANS; MALE; MIDDLE AGED; PARENTERAL NUTRITION; PREVALENCE; RETROSPECTIVE STUDIES; RISK FACTORS; STEM CELL TRANSPLANTATION;

EID: 33750221074     PISSN: 02683369     EISSN: 14765365     Source Type: Journal    
DOI: 10.1038/sj.bmt.1705493     Document Type: Article

References (30)

1. Ringden O, Deeg J. Clinical spectrum of graft-versus-host disease. In: Ferrara J, Deeg J, Burakoff S (eds). Graft- Vs-Host Disease. Marcel Dekker Inc.: New York, 1996, pp 525-560.
2. Vogelsang GB, Lee L, Bensen-Kennedy DM. Pathogenesis and treatment of graft-versus-host disease after bone marrow transplant. Annu Rev Med 2003; 54: 29-52.
3. Hill GR, Ferrara JL. The primacy of the gastrointestinal tract as a target organ of acute graft-versus-host disease: Rationale for the use of cytokine shields in allogeneic bone marrow transplantation. Blood 2000; 95: 2754-2759.
4. Horsley P, Bauer J, Gallagher B. Poor nutritional status prior to peripheral blood stem cell transplantation is associated with increased length of hospital stay. Bone Marrow Transplant 2005; 35: 1113-1116.
5. Kudsk KA, Croce MA, Fabian TC, Minard G, Tolley EA, Poret HA et al. Enteral versus parenteral feeding. Effects on septic morbidity after blunt and penetrating abdominal trauma. Ann Surg 1992; 215: 503-511; discussion 511-3.
6. Sigalet DL, Mackenzie SL, Hameed SM. Enteral nutrition and mucosal immunity: Implications for feeding strategies in surgery and trauma. Can J Surg 2004; 47: 109-116.
7. Svahn BM, Remberger M, Myrback KE, Holmberg K, Eriksson B, Hentschke P et al. Home care during the pancytopenic phase after allogeneic hematopoietic stem cell transplantation is advantageous compared with hospital care. Blood 2002; 100: 4317-4324.
8. Ringden O, Baryd I, Johansson B, Gahrton G, Groth CG, Lundgren G et al. Increased mortality by septicemia, interstitial pneumonitis and pulmonary fibrosis among bone marrow transplant recipients receiving an increased mean dose rate of total irradiation. Acta Radiologica - Oncology 1983; 22: 423-428.
9. Oakhill A, Pamphilon DH, Potter MN, Steward CG, Goodman S, Green A et al. Unrelated donor bone marrow transplantation for children with relapsed acute lymphoblastic leukaemia in second complete remission. Br J Haematol 1996; 94: 574-578.
10. Ringden O, Remberger M, Ruutu T, Nikoskelainen J, Volin L, Vindelov L et al. Increased risk of chronic graft-versus-host disease, obstructive bronchiolitis, and alopecia with busulfan versus total body irradiation: long-term results of a randomized trial in allogeneic marrow recipients with leukaemia. Nordic Bone Marrow Transplantation Group. Blood 1999; 93: 2196-2201.
11. Remberger M, Svahn BM, Hentschkc P, Lofgren C, Ringden O. Effect on cytokine release and graft-versus-host disease of different anti-T cell antibodies during conditioning for unrelated haematopoietic stem cell transplantation. Bone Marrow Transplant 1999; 24: 823-830.
12. Ringden O, Horowitz MM, Sondel P, Gale RP, Biggs JC, Champlin RE et al. Methotrexate, cyclosporine, or both to prevent graft-versus-host disease after HLA-identical sibling bone marrow transplants for early leukemia? Blood 1993; 81: 1094-1101.
13. Storb R, Deeg HJ, Whitehead J, Appelbaum F, Beatty P, Bensinger W et al. Methotrexate and cyclosporine compared with cyclosporine alone for prophylaxis of acute graft-versus host-disease after marrow transplantation for leukemia. N Engl J Med 1986-1 314: 729-735.
14. McSweeney PA, Storb R. Mixed chimcrism: Preclinical studies and clinical applications. Biol Blood Marrow Transplant 1999; 5: 192-203.
15. Glucksberg H, Storb R, Fefer A, Buckner CD, Neiman PE, Clift RA et al. Clinical manifestations of graft-versus-host disease in human recipients of marrow from HL-A-matched sibling donors. Transplantation 1974; 18: 295-304.
16. Ringden O, Remberger M, Persson U, I-jungman P, Aldener A, Andstrom E et al. Similar incidence of graft-versus-host disease using HLA-A, -B and -DR identical unrelated bone marrow donors as with HLA-identical siblings. Bone Marrow Transplant 1995; 15: 619-625.
17. Aschan J, Ringden O, Andstrorn E, I-jungman P, Lonnqvist B, Remberger M. Individualized prophylaxis against graft-versus-host disease in leukemic marrow transplant recipients. Bone Marrow Transplant 1994; 14: 79-87.
18. Gramlich L, Kichian K, Pinilla J, Rodych NJ, Dhaliwal R, Heyland DK. Does enteral nutrition compared to parenteral nutrition result in better outcomes in critically ill adult patients? A systematic review of the literature. Nutrition 2004; 20: 843 848.
19. Madara JL. Warner-Lambert/Parke-Davis Award lecture. Pathobiology of the intestinal epithelial barrier. Am J Pathol 1990; 137: 1273-1281.
20. Ohta K, Omura K, Hirano K, Kanehira E, Ishikawa N, Kato Y et al. The effects of an additive small amount of a low residual diet against total parenteral nutrition-induced gut mucosal barrier. Am J Surg 2003; 185: 79-85.
21. Hanson LA, Ablstedt S, Andersson B, Carlsson B, Dahlgren U, Lidin-Janson G et al. Keynote address - Sixteenth National Meeting of the Reticuloendothelial Society San Antonio, Texas, December 5-8, 1979. The biologic properties of secretory IgA. J Reticuloendothel Soc 1980; 28: ls-19s.
22. Yang H, Kiristioglu I, Fan Y, Forbush B, Bishop DK, Antony PA et al. Interferon-gamma expression by intraepithelial lymphocytes results in a loss of epithelial barrier function in a mouse model of total parenteral nutrition.Ann Surg 2002; 236: 226-234.
23. Fowler DH, Gress RE. Th2 and Tc2 cells in the regulation of GVHD, GVL, and graft rejection: Considerations for the allogeneic transplantation therapy of leukemia and lymphoma. Leuk Lymphoma 2000; 38: 221-234.
24. Hill GR, Crawford JM, Cooke KR, Brinson YS, Pan L, Ferrara JL. Total body irradiation and acute graft-versus-host disease: The role of gastrointestinal damage and inflammatory cytokines. Blood 1997; 90: 3204-3213.
25. Reddy P, Ferrara JL. Immunobiology of acute graft-vcrsus-host disease. Blood Rev 2003; 17: 187-194.
26. Mowat AM. Antibodies to IFN-gamma prevent immunologically mediated intestinal damage in murine graft-versus-host reaction. Immunology 1989; 68: 18-23.
27. Murai M, Yoneyama H, Ezaki T, Suematsu M, Terashima Y, Harada A et al. Peyer's patch is the essential site in initiating murine acute and lethal graft-versus-host reaction. Nat Immunol 2003; 4: 154-160.
28. Goldberg J, Jacobsohn DA, Zahurak ML, Vogelsang GB. Gastrointestinal toxicity from the preparative regimen is associated with an increased risk of graft-versus-host disease. Biol Blood Marrow Transplant 2005; 11: 101-107.
29. Murray SM, Pindoria S. Nutrition support for bone marrow transplant patients. Cochrane Database Syst Rev 2002; 2: CD002920.
30. Szeluga DJ, Stuart RK, Brookmeyer R, Utermohlen V, Santos GW. Nutritional support of bone marrow transplant recipients: A prospective, randomized clinical trial comparing total parenteral nutrition to an enteral feeding program. Cancer Res 1987; 47: 3309-3316.